Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| t AI startup automating customer-facing operations with AI agents | $15M | Seed | AI | Germany | Investors | |
| A AbstractCompany profile Abstract provides a streaming security platform for real-time threat detection and response Abstract provides a streaming security platform for real-time threat detection and response |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
| $25M |
| Growth |
| Cybersecurity |
| United States |
| Investors |
| CH Automates the financial infrastructure of American healthcare | $120M | Series DSeries C+ | Healthtech | United States | Investors |
| TA Tikva AllocellCompany profile Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors | $8M | Series A | Biotech | Singapore | Investors |
| TB Transcripta BioCompany profile AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases | $24M | Series A | Biotech | United States | Investors |
| P PawPay turns any policy into pet insurance that pays vet directly | Undisclosed | Undisclosed | Fintech | United States | Investors |
| CT Crystalys TherapeuticsCompany profile Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout | $130M | Series B | Biotech | United States | Investors |
| A ArrakisCompany profile AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows | $30M | Series A | Industrial tech | United Kingdom | Investors |
| O OsspreyCompany profile Develops technology that detects malicious code in open-source software before it reaches production Develops technology that detects malicious code in open-source software before it reaches production | $2.7M | Pre-SeedPre-seed | Cybersecurity | United Kingdom | Investors |
| NB N-Zyme BiomedicalCompany profile Developing first-in-class therapies targeting pepsin for reflux disease Developing first-in-class therapies targeting pepsin for reflux disease | $4.6M | Series A | Biotech | United States | Investors Undisclosed |